Clicky

Ion Beam Applications S.A.(0GZK)

Description: Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.


Keywords:

Home Page: www.iba-worldwide.com

0GZK Technical Analysis

3, Chemin du Cyclotron
Louvain-la-Neuve, 1348
Belgium
Phone: 32 1 047 58 11


Officers

Name Title
Mr. Pierre Mottet Chairman of The Board
Mr. Olivier Legrain CEO, MD & Executive Director
Mr. Yves Jongen Founder, Chief Research Officer, MD & Executive Director
Ms. Soumya Chandramouli Chief Financial Officer
Marc Van der Burght Chief Operation Officer
Olivier Lechien Corporate Communication Director
Thomas Canon Sustainability Program Director
Henri de Romree Deputy CEO
Bruno Scutnaire President of IBA RadioPharma Solutions

Exchange: LSE

Country: GB : United Kingdom of Great Britain and Northern Ireland

Currency: Euro (€)

Forward PE: 0
Trailing PE: 1.3163
Price-to-Book MRQ: 0
Price-to-Sales TTM: 1.0647
IPO Date:
Fiscal Year End: December
Full Time Employees: 1943
Back to stocks